Compounds > eg 626
Page last updated: 2024-08-23

eg 626 and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

eg 626 has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bristol, JA; Cain, MH; Weishaar, RE1
Adachi, K; Numano, F1

Reviews

1 review(s) available for eg 626 and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

ArticleYear
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity

1985

Other Studies

1 other study(ies) available for eg 626 and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

ArticleYear
Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
    Japanese journal of pharmacology, 1977, Volume: 27, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Aorta; Blood Platelets; Brain; In Vitro Techniques; Liver; Mice; Muscles; Myocardium; Papaverine; Phosphodiesterase Inhibitors; Phthalazines; Rats; Skin; Theophylline

1977